• Precision Rescue of F508del CFTR: VX-661 and Calnexin Insigh

  2026-05-20

  This thought-leadership article examines the mechanistic advances and translational strategies enabled by VX-661 (F508del CFTR corrector), with a focus on the interplay between calnexin-dependent folding and pharmacological rescue of CFTR variants. Drawing on recent deep mutational scanning and workflow optimization studies, the article provides actionable guidance for researchers developing precision cystic fibrosis therapies. APExBIO's VX-661 is highlighted as a cornerstone tool for reliable, data-driven modulation of CFTR function.

• Deracoxib–Doxorubicin Effects on Normal Canine Mammary Cells

  2026-05-20

  This study investigates how deracoxib, a selective COX-2 inhibitor, modulates doxorubicin-induced cytotoxicity and apoptosis in normal canine mammary epithelial cells. The findings reveal that deracoxib reduces doxorubicin toxicity and nitric oxide overproduction, providing mechanistic insight for safer chemotherapy regimens in veterinary oncology.

• BIBP 3226 trifluoroacetate: Illuminating the Adipose-Neural

  2026-05-19

  Explore how BIBP 3226 trifluoroacetate empowers advanced cardiovascular and neuropeptide signaling research by dissecting the adipose-neural axis in arrhythmia. This in-depth analysis reveals unique mechanistic insights and practical protocols, distinguishing APExBIO's solution from standard approaches.

• Axitinib (AG 013736): Integrative Assay Design and Quantitat

  2026-05-19

  Discover how Axitinib (AG 013736) enables advanced VEGF pathway modulation with quantitative rigor. This article uniquely bridges in vitro assay innovation and translational cancer research, offering deeper scientific context for optimizing angiogenesis inhibition studies.

• N3-kethoxal: Precision Probing for RNA Structure & DNA Mappi

  2026-05-18

  N3-kethoxal (3-(2-azidoethoxy)-1,1-dihydroxybutan-2-one) stands out as a membrane-permeable nucleic acid probe, enabling high-resolution RNA secondary structure probing and genomic mapping of accessible DNA. Its compatibility with click chemistry and in vivo workflows empowers advanced detection of dynamic nucleic acid interactions, setting a new standard for reproducibility and experimental flexibility.

• miR-3180 Suppresses HCC Growth by Targeting Lipid Metabolism

  2026-05-18

  Hong et al. (2023) identify miR-3180 as a crucial regulator in hepatocellular carcinoma, directly inhibiting both fatty acid synthesis and uptake via SCD1 and CD36. Their findings suggest miR-3180's potential as a therapeutic and prognostic marker, offering a new avenue in targeting reprogrammed lipid metabolism in cancer.

• Metronidazole: Applied Workflows for OAT3 Inhibition & Micro

  2026-05-17

  Metronidazole (2-(2-methyl-5-nitroimidazol-1-yl)ethanol) delivers precise control over OAT3-mediated transport and anaerobic bacterial targeting, enabling advanced research into immune-microbiota interactions and drug-drug interaction modulation. Learn how to optimize experimental protocols and troubleshoot common pitfalls with this high-purity APExBIO reagent.

• BAPTA-AM (SKU B4758): Reliable Calcium Chelation in Assays

  2026-05-16

  This article delivers practical, data-backed guidance for researchers using BAPTA-AM (SKU B4758) as a cell-permeable calcium chelator in cell viability, apoptosis, and neuroprotection workflows. Grounded in real laboratory scenarios and recent literature, it demonstrates how APExBIO's BAPTA-AM addresses challenges in assay reproducibility and intracellular calcium control. Explore validated protocols and evidence-based answers to common experimental design and product selection questions.

• ER Stress and Cytokine Storms Drive Prometastatic States in

  2026-05-15

  Conod et al. (2022) demonstrate that tumor cells surviving impending cell death undergo ER stress and nuclear reprogramming, giving rise to stable prometastatic cell states (PAMEs). These findings clarify how metastasis-initiation is linked to cellular stress responses and signal a need for targeted interventions against these transitional states.

• PAD4-IN-2 TFA: Tumor-Targeted PAD4 Inhibitor with Immune Mod

  2026-05-15

  PAD4-IN-2 TFA (Compound 5i TFA) is a highly selective PAD4 inhibitor that targets tumor cells via meta-phenylboronic acid modification. The compound suppresses histone H3 citrullination and neutrophil extracellular trap (NET) formation, significantly inhibiting tumor growth and metastasis with minimal toxicity.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Redefining Selecti

  2026-05-14

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride advances endothelial injury and intracellular pH regulation research through selective Na+/H+ exchanger inhibition. This article reveals novel practical assay implications and bridges translational gaps overlooked in prior reviews.

• Axitinib (AG 013736): Precision in VEGF Pathway Modulation

  2026-05-14

  Axitinib (AG 013736) delivers nanomolar-selective VEGFR blockade for advanced angiogenesis and tumor growth inhibition assays. This guide bridges in vitro best practices, protocol optimization, and troubleshooting tips, enabling reproducible, translational results in cancer biology research.

• PtrbZIP12 Phosphorylation Enhances Drought Resistance in Pop

  2026-05-13

  The referenced study demonstrates that phosphorylation of the bZIP transcription factor PtrbZIP12 is essential for activating key drought-responsive genes (PtrDHN and PtrPOD) in Populus trichocarpa. These findings clarify a phosphorylation-dependent regulatory mechanism, suggesting new avenues for plant stress adaptation research and molecular breeding strategies.

• Benzyl Quinolone Carboxylic Acid: Precision Modulation of M1

  2026-05-13

  Explore how Benzyl Quinolone Carboxylic Acid (BQCA) selectively modulates M1 muscarinic acetylcholine receptors, advancing cognitive function research. This article uniquely unpacks the latest GRK interaction mechanisms to empower assay optimization and translational neuroscience.

• USP36-Snail1 Axis Drives Ribosome Biogenesis in Tumor Stress

  2026-05-12

  This study uncovers how the deubiquitinase USP36 stabilizes nucleolar Snail1, enabling cancer cell survival under ribotoxic stress by promoting ribosome biogenesis. The findings clarify why solid tumors resist ribosome inhibitors like HHT and suggest new therapeutic targets for overcoming this resistance.

15639 records 1/1043 page Next 12345 下5页 Last page